A study of drug-resistant childhood epilepsy testing the new ILAE criteria

Area of Science:

• Pediatric Neurology
• Epilepsy Research
• Clinical Trials

Background:

• Drug-resistant epilepsy (DRE) affects a significant portion of pediatric patients.
• Accurate identification of DRE is crucial for effective treatment strategies.
• The International League Against Epilepsy (ILAE) proposed new criteria for defining DRE.

Purpose of the Study:

• To evaluate the utility of the new International League Against Epilepsy (ILAE) definition for drug-resistant epilepsy in a pediatric cohort.
• To assess the proportion of children meeting the new ILAE criteria for DRE.
• To analyze treatment outcomes and remission probabilities based on the ILAE definition.

Main Methods:

• A cohort of children under 14 with at least two unprovoked seizures was retrospectively analyzed.
• Patients were followed for an average of 90 months.
• Seizure freedom and DRE status were assessed based on the ILAE criteria and treatment regimens.

Main Results:

• 19% of treated patients (n=459) met the new ILAE criteria for drug-resistant epilepsy.
• Probabilities of seizure freedom decreased with subsequent antiepileptic drug regimens (65% first, 21% fourth+).
• Children meeting DRE criteria often had early onset, developmental delays, structural causes, or specific epileptic syndromes.

Conclusions:

• The new ILAE criteria identify a larger group of pediatric patients with drug-resistant epilepsy compared to previous definitions.
• A substantial proportion of patients classified as DRE by ILAE criteria eventually achieve remission.
• Refining DRE definitions to include factors like failure of a third antiepileptic drug or high seizure frequency may improve identification of truly refractory cases.